Pipeline
| Programs | Indication | Preclinical | Phase 1 | Phase 2 | Phase 3 |
|---|---|---|---|---|---|
Breast Cancer |
|||||
| pelareorep + combination | mBC (HR+/HER2-) |
Preclinical Phase complete
|
Phase 1 Phase complete
|
Phase 2 Phase in progress
|
Phase 3 Phase not started
|
pelareorep +
|
mBC (HR+/HER2-) |
Preclinical Phase complete
|
Phase 1 Phase in progress
|
Phase 2 Phase not started
|
Phase 3 Phase not started
|
pelareorep +
|
Early BC |
Window of Opportunity Study
Preclinical Phase complete
|
Phase 1 Phase in progress
|
Phase 2 Phase not started
|
Phase 3 Phase not started
|
Gastro-Intestinal Cancer |
|||||
pelareorep +
|
Pancreatic Cancer |
Preclinical Phase complete
|
Phase 1 Phase complete
|
Phase 2 Phase in progress
|
Phase 3 Phase not started
|
Multiple Myeloma |
|||||
pelareorep +
|
R/R MM |
Preclinical Phase complete
|
Phase 1 Phase in progress
|
Phase 2 Phase not started
|
Phase 3 Phase not started
|
pelareorep +
|
R/R MM |
Preclinical Phase complete
|
Phase 1 Phase in progress
|
Phase 2 Phase not started
|
Phase 3 Phase not started
|
Planned Studies